BNP Paribas Financial Markets’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,090
Closed -$31.5K 6005
2025
Q4
$31.5K Buy
1,090
+559
+105% +$10.6K ﹤0.01% 4890
2025
Q3
$4.12K Buy
531
+420
+378% +$3.15K ﹤0.01% 5111
2025
Q2
$818 Sell
111
-7,947
-99% -$69.8K ﹤0.01% 5167
2025
Q1
$69.3K Sell
8,058
-6,388
-44% -$98.6K ﹤0.01% 4177
2024
Q4
$516K Buy
14,446
+4,958
+52% +$256K ﹤0.01% 3283
2024
Q3
$448K Sell
9,488
-3,955
-29% -$174K ﹤0.01% 2906
2024
Q2
$676K Buy
13,443
+10,214
+316% +$738K ﹤0.01% 2494
2024
Q1
$362K Buy
3,229
+1,529
+90% +$152K ﹤0.01% 3016
2023
Q4
$98.6K Sell
1,700
-3,234
-66% -$130K ﹤0.01% 3401
2023
Q3
$157K Buy
4,934
+1,974
+67% +$93.8K ﹤0.01% 3186
2023
Q2
$243K Sell
2,960
-5,908
-67% -$864K ﹤0.01% 2934
2023
Q1
$911K Buy
8,868
+3,961
+81% +$556K ﹤0.01% 2383
2022
Q4
$719K Sell
4,907
-4,600
-48% -$777K ﹤0.01% 2367
2022
Q3
$1.61M Sell
9,507
-12,081
-56% -$1.96M ﹤0.01% 2121
2022
Q2
$2.49M Sell
21,588
-4,517
-17% -$425K 0.01% 1625
2022
Q1
$2.6M Buy
26,105
+1,368
+6% +$160K 0.01% 1651
2021
Q4
$3.85M Buy
24,737
+21,866
+762% +$4.25M 0.01% 1526
2021
Q3
$677K Buy
2,871
+2,771
+2,771% +$810K ﹤0.01% 2604
2021
Q2
$34K Sell
100
-178
-64% -$67.4K ﹤0.01% 3393
2021
Q1
$112K Buy
278
+15
+6% +$7.28K ﹤0.01% 3303
2020
Q4
$175K Sell
263
-246
-48% -$137K ﹤0.01% 2949
2020
Q3
$237K Buy
509
+353
+226% +$178K ﹤0.01% 2678
2020
Q2
$91.3K Sell
156
-289
-65% -$98.7K ﹤0.01% 2804
2020
Q1
$64.8K Buy
445
+99
+29% +$17.3K ﹤0.01% 3427
2019
Q4
$49.6K Buy
346
+218
+170% +$15.9K ﹤0.01% 3655
2019
Q3
$5.07K Buy
128
+2
+2% +$145 ﹤0.01% 4273
2019
Q2
$12.7K Buy
126
+19
+18% +$2.24K ﹤0.01% 4050
2019
Q1
$14.1K Buy
107
+96
+873% +$12.1K ﹤0.01% 3977
2018
Q4
$1.16K Sell
11
-8
-42% -$1.27K ﹤0.01% 3903
2018
Q3
$4.73K Hold
19
﹤0.01% 4083
2018
Q2
$8.45K Sell
19
-68
-78% -$29.8K ﹤0.01% 3858
2018
Q1
$34.3K Buy
87
+44
+102% +$17.4K ﹤0.01% 3735
2017
Q4
$17.5K Buy
+43
New +$18.8K ﹤0.01% 3978

Other funds holding MRSN